Thus, our experiments define CD11b+CD11c+ MDSCs as the subpopulation of in vitro-generated MDSCs able to protect BMT mice from GVHD development without impairing antitumor cytotoxicity. The gene discussed is ITGAM; the disease is graft versus host disease.